Zach Hornby, Boundless Bio CEO
May 16, 2023 07:00 AM EDTUpdated May 19, 02:46 PM
Financing

Bound­less Bio snags $100M to en­ter clin­ic and fight can­cer by tar­get­ing cir­cu­lar DNA bits

Andrew Dunn

Senior Biopharma Correspondent

Bound­less Bio raised $100 mil­lion in a Se­ries C round, the San Diego biotech said Tues­day, as it brings its un­usu­al …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

Deer­field wins fight to ac­quire Sin­gu­lar Ge­nomics, beat­ing out Tang Cap­i­tal’s Con­cen­tra

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

A service from the Financial Times